StockNews.com Initiates Coverage on SenesTech (NASDAQ:SNES)

Equities research analysts at StockNews.com assumed coverage on shares of SenesTech (NASDAQ:SNESGet Free Report) in a report issued on Wednesday. The brokerage set a “sell” rating on the stock.

Separately, HC Wainwright reissued a “buy” rating and issued a $3.50 target price on shares of SenesTech in a research note on Tuesday, May 14th.

Check Out Our Latest Research Report on SNES

SenesTech Stock Performance

NASDAQ SNES opened at $0.57 on Wednesday. SenesTech has a twelve month low of $0.52 and a twelve month high of $15.00. The company has a current ratio of 6.91, a quick ratio of 5.69 and a debt-to-equity ratio of 0.03. The firm has a 50-day simple moving average of $0.71 and a 200 day simple moving average of $0.83.

SenesTech (NASDAQ:SNESGet Free Report) last released its quarterly earnings data on Thursday, May 9th. The company reported ($0.36) earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of ($0.34) by ($0.02). SenesTech had a negative net margin of 545.82% and a negative return on equity of 181.46%. The firm had revenue of $0.42 million for the quarter, compared to the consensus estimate of $0.43 million. During the same quarter in the prior year, the firm posted ($15.85) earnings per share. As a group, research analysts forecast that SenesTech will post -1.1 EPS for the current fiscal year.

Institutional Inflows and Outflows

A hedge fund recently bought a new stake in SenesTech stock. Armistice Capital LLC purchased a new stake in SenesTech, Inc. (NASDAQ:SNESFree Report) during the third quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The fund purchased 70,425 shares of the company’s stock, valued at approximately $30,000. Armistice Capital LLC owned approximately 1.94% of SenesTech as of its most recent SEC filing. 5.19% of the stock is currently owned by institutional investors and hedge funds.

SenesTech Company Profile

(Get Free Report)

SenesTech, Inc develops a technology for managing animal pest populations through fertility control. It offers ContraPest, a liquid bait that limits reproduction of male and female rats. The company was incorporated in 2004 and is headquartered in Phoenix, Arizona.

Further Reading

Receive News & Ratings for SenesTech Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for SenesTech and related companies with MarketBeat.com's FREE daily email newsletter.